argenx S…announced positive topline results from the ALKIVIA Phase 3 study evaluating VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) in adults with autoimmune myositis.

Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) - argenx

Aug 17, 2026